| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.81 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.007 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |